No two cancers are completely alike – they each have their own unique genetic makeup. As discussed by the Canadian Cancer Society[1], personalized medicine is a different approach that allows for cancer treatments to be customized based on an individual’s genetic information. This type of treatment tries to target the specific genetic changes that are unique to an individual’s cancer. As this is a relatively new concept, personalized medicine still requires additional research.
The Canadian Breast Cancer Symposium aims to explore this topic further and develop a personalized approach to breast cancer management. Upon attending, participants will be able to:
- Identify significant risk factors in individual care
- Utilize appropriate screening tools
- Discuss the directions in which research is headed
- Identify applications for practice changing results
- Identify a management strategy for breast cancer patient follow-up
The 2019 Canadian Breast Cancer Symposium will take place on June 13-14, 2019 at the Westin Harbour Castle in Toronto. General surgeons, breast surgeons, surgical oncologists, radiation oncologists, medical oncologists, pathologists, general practitioners, and residents and fellows are encouraged to attend.
For more information and to register, please visit https://www.breastsymposium.ca/.
________________________________________________________
[1] http://www.cancer.ca/en/research-horizons/a/1/b/personalized-medicine-is-transforming-cancer-treatment/